Glaxosmithkline ADR rep 2 ord shs: Ownership
| Ownership Information |
| Shares Outstanding |
2.60 Bil | | Institutional Ownership (%) | 8.57 | | Top 10 Institutions (%) | 5.50 | | Mutual Fund Ownership (%) | .06 | | 5%/Insider Ownership (%) | 1.00 | | Float (%) | 99.00 |
| Ownership Activity |
| Description | # of Holders | Shares |
| Total Positions |
537 | 222,364,544 | | New Positions | 47 | 0 | | Soldout Positions | 134 | 0 | | Net Position Change | -163 | -6,992,994 | | Buyers | 198 | 10,000,769 | | Sellers | 361 | -16,993,764 |
| advertisement |
|
|
|---|
| Institution Name |
Shs Held |
Shs Chg |
%Chg |
$Chg* |
%Out |
%Port |
Rpt Date |
| Dodge & Cox |
67,266,968 |
1,492,942 |
2.3 |
333,263,840 |
2.6 |
3.5 |
09-30-09 |
| State Street Global Advisors (US) |
15,537,847 |
-27,715 |
-0.2 |
63,813,376 |
0.6 |
0.1 |
09-30-09 |
| NFJ Investment Group LLC |
9,434,050 |
-405,100 |
-4.1 |
25,023,756 |
0.4 |
2.0 |
09-30-09 |
| Evergreen Investment Management Company, LLC |
8,562,620 |
-33,702 |
-0.4 |
34,515,096 |
0.3 |
1.1 |
09-30-09 |
| PRIMECAP Management Company |
8,204,754 |
-79,300 |
-1.0 |
31,411,364 |
0.3 |
0.6 |
09-30-09 |
| Oppenheimer Capital L.L.C. |
7,254,395 |
-586,210 |
-7.5 |
9,534,165 |
0.3 |
2.0 |
09-30-09 |
| Brandes Investment Partners, LP |
7,237,594 |
-451,377 |
-5.9 |
14,229,104 |
0.3 |
1.4 |
09-30-09 |
| BNY Mellon Wealth Management |
6,842,735 |
-141,639 |
-2.0 |
13,152,937 |
0.3 |
1.2 |
12-31-09 |
| AllianceBernstein L.P. |
6,785,818 |
-468,031 |
-6.5 |
11,756,645 |
0.3 |
0.2 |
09-30-09 |
| Delaware Investments |
5,314,580 |
-301,748 |
-5.4 |
11,498,024 |
0.2 |
0.9 |
09-30-09 |
| Fisher Investments |
5,140,450 |
-47,332 |
-0.9 |
12,214,746 |
0.2 |
0.7 |
12-31-09 |
| Wellington Management Company, LLP |
4,183,481 |
-35,800 |
-0.8 |
16,179,943 |
0.2 |
0.1 |
09-30-09 |
| Lazard Asset Management, L.L.C. |
3,074,857 |
-701,764 |
-18.6 |
-11,978,186 |
0.1 |
0.4 |
09-30-09 |
| INVESCO Institutional (N.A.), Inc. |
2,923,002 |
-148,058 |
-4.8 |
6,956,549 |
0.1 |
0.8 |
09-30-09 |
| Janus Capital Management LLC |
2,576,037 |
1,876,785 |
268.4 |
77,067,656 |
0.1 |
0.2 |
09-30-09 |
- *Category Headings:
- Shs Held - shares held at report date
- Shs Chg - position change within reporting period
- %Chg - % change
- $Chg - market value of the position change
- %Out - % of shares outstanding
- %Port - % Portfolio
- Rpt Date - report date
Page generated 2/10/2010 9:01 AM Eastern Time